10 November 2023FeaturesPatentsSarah Gibbs and Emma Lyons

Weight loss drugs: The impact of NICE and the FDA

In March 2023, the National Institute for Health and Care Excellence (NICE) published guidelines recommending the use of semaglutide for weight management. Semigltuide was officially launched for use in the whole of the UK in September 2023.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Navigating IP challenges in the wearable tech space

Google appoints new head of litigation amid legal restructuring

Takeaways from landmark UPC decision: Novartis v Celltrion

Combatting cybersquatters and bad actors with UDRPs

DexCom suffers second patent revocation at hands of UPC

Q&A: Counsel on leading Paltalk’s $65.7m win against Cisco

Plastic evolution: how Lego is using IP to build a more sustainable brand

INTA sounds warning to SCOTUS over corporate liability case

Weight loss drugs: The impact of NICE and the FDA

More on this story

Editor's picks

Editor's picks

More articles